Zimmer Biomet Holdings, Inc. (ZBH) closed Tuesday at $91.59 per share, a gain of 3.74% from the previous session. The medical device company's market capitalization stood at $16.84 billion as of October 6, 2026.
Despite the strong single-day advance, the stock's performance over a longer stretch tells a more cautious story. ZBH is nearly unchanged over the past seven days, down just 0.03%, while the 30-day period shows a decline of 6.61%.
The gap between Tuesday's gain and the 30-day trend suggests the session's move has not been enough to fully offset the selling pressure seen over the prior month. Shares remain well below where they stood a month ago even after the day's rally.
Zimmer Biomet specializes in musculoskeletal healthcare products including orthopedic reconstructive implants and related surgical equipment. The stock's recent volatility reflects broader shifts in sentiment toward the medical device sector.
